The Human Research Office Investigational Review Board approved this study.
A radiologist who was experienced with interventional magnetic resonance
imaging performed all needle biopsies in consultation with an experienced
orthopaedic surgical oncologist (J.E.R.) as recommended by the Musculoskeletal
Tumor
Society10,11.
Subject and Lesion Characteristics
We performed a retrospective study of the results of forty-five consecutive
magnetic resonance imaging-guided musculoskeletal biopsies performed at our
institution over a nine-year period from July 1, 1994, to August 31, 2003.
During the same time-period at our institution, 685 image-guided biopsies of
musculoskeletal lesions were done with computed tomography, 109 were done with
ultrasonography, and seven were performed with fluoroscopy. The ages of the
subjects included in the study ranged from fifteen to seventy-eight years
(mean, 50.3 years); twenty-one patients were male, and twenty-four were
female. The biopsies were stratified into three subgroups—bone (twenty),
extra-articular soft tissue (eighteen), and intra-articular soft tissue
(seven)—because there are differences among these lesions with respect
to needle biopsy technique and pathological evaluation. Six bone lesions were
located in the ilium; six, in the humerus; five, in a vertebra; two, in the
femur; and one, in the tibia. The maximum dimension of the bone lesions ranged
from 0.7 to 4.0 cm, with a mean of 2.8 cm. Eleven extra-articular soft-tissue
lesions were located in the thigh; three, in the calf; two, in the pelvis;
one, in the arm; and one, in the hand. The maximum dimension of those lesions
ranged from 1.8 to 14 cm, with a mean of 4.3 cm. Five intra-articular
soft-tissue lesions were in the knee, one was in the hip, and one was in the
ankle.
Indications for Magnetic Resonance Imaging Guidance
The main reasons for using magnetic resonance imaging guidance were the
need to improve lesion conspicuity compared with that provided by other
modalities, the need for site-specific targeting within the lesion, and the
need for realtime guidance. The indications for use of magnetic resonance
imaging for the bone lesions included the need to produce superior tissue
contrast for a lesion that could not be adequately visualized with computed
tomography imaging (nine cases), with one case related to streak artifacts
limiting the use of computed tomography to localize a lesion adjacent to an
intramedullary rod; the need for real-time guidance for targeting a lesion
where thin superficial tissues would have made it more difficult for the
needle to remain firmly situated while the patient was moved in and out of a
computed tomography scanner (five cases); the need for selective targeting to
sample a specific portion of a heterogeneous lesion (three); avoidance of
ionizing radiation (one); and a biopsy immediately preceding magnetic
resonance imaging-guided cryoablation of a tumor (two). The indications for
the extra-articular soft-tissue lesions included the need to provide lesion
conspicuity that was superior to that provided by ultrasound and/or computed
tomography in eight cases, with five of those cases representing an
abnormality detected by surveillance magnetic resonance imaging in a patient
who had undergone a resection of a sarcoma and one case related to severe
streak artifacts limiting the use of computed tomography for localizing a
lesion adjacent to an intramedullary rod. The other indications for the
extra-articular soft-tissue lesions were a failed (nondiagnostic)
ultrasound-guided biopsy (five cases) and the need for site-specific targeting
(five). The indications for the intra-articular soft-tissue lesions were a
primary diagnosis of a proliferative synovial process (four cases), the need
to rule out recurrent pigmented villonodular synovitis (one), and an
atypical-appearing ganglion (two). The majority of those cases were referred
primarily for a magnetic resonance imaging-guided biopsy because of the
intra-articular location of the lesion, and one was referred after a computed
tomography-guided biopsy was nondiagnostic.
Magnetic Resonance Imaging Interventional System
All procedures were performed with use of a 0.5-T open-configuration
magnetic resonance imaging system (SIGNA SP; GE Healthcare, Waukesha,
Wisconsin). The magnetic resonance imaging system has two toroidal magnet
components separated by a 56-cm-wide vertically oriented opening providing
access to the anatomy being imaged. During procedures, imaging is performed
with use of a set of flexible, transmitreceive radiofrequency coils that have
openings allowing placement of biopsy
devices12.
Biopsy Procedure
Patient Preparation
The patient and a flexible surface coil were positioned such that the entry
point and the lesion were within the imaging field with the lesion as close to
the magnet isocenter as possible. General anesthesia was used for five
subjects, spinal anesthesia was used for one pregnant patient, intravenous
conscious sedation was used for twenty-six patients, and local anesthesia only
was used for thirteen patients. A sterile field, including sterile draping of
the coil and the side walls of the magnet, was used. Local anesthesia (1% to
2% lidocaine for skin and subcutaneous infiltration and 0.25% bupivacaine for
deep or periosteal infiltration) was administered in all cases.
Prospective Planning
Pre-intervention imaging was performed in two or three orthogonal planes
prior to needle placement to determine the best needle approach and to
optimize the pulse sequences for lesion visibility. Intravenous
gadolinium-based contrast material was used when the operator thought that
contrast enhancement might improve lesion visualization or identify more
vascular portions of the lesion that might produce a better diagnostic yield.
Intravenous gadopentetate dimeglumine (Magnevist; 0.1 mmol/kg of body weight)
was used in four subjects (one bone lesion, two extra-articular soft-tissue
lesions, and one intra-articular soft-tissue lesion).
Guidance Methods
The guidance method, which was chosen by the operator, consisted of
externally referenced frameless stereotaxy with use of optical tracking
(twenty-one lesions) or self-referencing with use of anatomical landmarks
(twenty-four lesions). Accordingly, the biopsies were performed with use of an
interactive or sequential imaging mode.
The interactive mode was performed with an externally referenced
needle-guidance method. This method involved use of an integrated optical
tracking system (Pixsys 3000 Flashpoint Position Encoder; Image-Guided
Technologies, Boulder, Colorado). The optical tracking is achieved with a
needle-holder that has two flashing infrared light-emitting diodes that are
detected by three sensors mounted within the magnet system. Using simple
triangulation, the magnetic resonance imaging system console computer has
continuous information about the tip position and angle of the instrument.
Images can be generated on the basis of the position of the instrument tip in
any image plane. Positioning the optically tracked tools and selecting the
related image planes provide an interactive way to localize targets, define
trajectories, and review alternative access routes. This results in one-step
localization. Because the needle-holder is localized during the biopsy, the
images are in the same plane as the needle and the target can be visualized
continuously while the needle is advanced. In this interactive mode, the
needle location and trajectory are visualized on images acquired in nearly
real-time while the intervention is being performed. Interactive imaging
involved use of a fast gradient-echo sequence (repetition time, 15.7 msec;
echo time, 7.5 msec; flip angle, 30°; 256 × 128 matrix; section
thickness, 10 mm) such that images were updated about every two seconds.
The sequential mode involved use of a self-referenced guidance method. With
this method, a marker that was visible on magnetic resonance imaging (a
vitamin-E capsule or the operator's finger) was placed over the lesion and
near the anticipated entry site. The trajectory is calculated from the
position of the target relative to the markers. With self-referenced guidance,
sequential imaging between needle manipulations was used. For localization of
needle placement, spoiled gradient-echo (repetition time, 120.0 msec; echo
time, 6.6 msec; 256 × 128 matrix; one signal acquired; section
thickness, 10 mm) or fast spin-echo (repetition time, 200 msec; echo time, 102
msec; 256 × 128 matrix; one signal acquired; section thickness, 5 mm)
image acquisitions were used to generate images in a three or five-section
mode. Each pulse sequence took thirty to sixty seconds to acquire images,
during which time the needle could be manipulated because it generated motion
artifact. A more rapid method involves using a fast gradient-echo sequence
(repetition time, 14.1 msec; echo time, 6.6 msec; flip angle, 60°; 256
× 128 matrix) in a single-section mode in which an image is displayed
approximately every two seconds, allowing quicker needle manipulation and
confirmatory imaging. Oblique and double-oblique planes were used when
needed.
Biopsy Technique and Needles
There was no specific protocol for performing a core-needle biopsy or a
fine-needle aspiration or for obtaining a specific number of samples; these
were determined by the operator at the time of the biopsy. The customary
practice at our institution is to perform both a core-needle biopsy and a
fine-needle aspiration whenever possible. Both procedures were performed for
thirty-one lesions, only a core-needle biopsy was done for ten, and only a
fine-needle aspiration was done for four. Therefore, there was a total of
forty-one core-needle biopsies (for seventeen bone, seventeen extra-articular
soft-tissue, and seven intra-articular soft-tissue lesions) and thirty-five
fine-needle aspirations (for fourteen bone, fourteen extra-articular
soft-tissue, and seven intra-articular soft-tissue lesions). Several types of
commercially available magnetic resonance imaging-compatible needles were used
in isolation or combination for each case.
Core-needle biopsy: For the twenty bone biopsies, cortical
penetration was achieved by hand with use of a 3, 4, or 6-mm bone-penetration
needle (Bone Biopsy set manual; In-vivo, Orlando, Florida). Power drills were
not used. Multiple samples were then obtained coaxially. Initially a trephine
was used for all twenty biopsies. The sample was then supplemented with use of
a manual or semiautomatic side-cutting-needle biopsy gun (described below) in
three cases and with a vacuum-assisted front-cutting needle (described below)
in four cases because the initial sample quality and consistency had been
noted to be insufficient by the radiologist performing the procedure. The
core-needle-biopsy samples of the eighteen extra-articular soft-tissue lesions
were obtained with one or a combination of three devices of various lengths: a
14, 16, or 18-gauge semiautomatic biopsy gun (MRI Devices, Schwerin, Germany),
a 16 or 18-gauge biopsy gun (MRI BIO-GUN Automated Biopsy System; E-Z-EM, Lake
Success, New York), or a 16-gauge vacuum-assisted front-cutting coring needle
(Techna Cut Biopsy Needle; Manan Medical Products, Inc., Wheeling, Indiana).
For deeply situated lesions, multiple biopsy samples were obtained through a
single puncture site by using an introducer needle and a coaxial technique.
The biopsy gun was used in all eighteen subjects, and the vacuum-assisted
front-cutting coring needle was used in addition in five subjects because the
quality of the initial small sample was not adequate. The biopsies of the
seven intra-articular soft-tissue lesions were accomplished in a manner
similar to that used at the extra-articular soft-tissue sites. A side-cutting
needle (biopsy gun) was used in six subjects, and a vacuum-assisted
front-cutting coring needle was used in one subject. Three to six biopsy
specimens were routinely obtained and were sent in buffered formalin or saline
solution for histological analysis.
Fine-needle aspiration: Fine-needle aspirations of bone,
extra-articular soft-tissue, and intra-articular soft-tissue sites were
typically accomplished coaxially by means of an introducer. In some
soft-tissue areas that were superficial and in which it would have been
difficult to maintain the introducer position, direct placement was performed.
All fine-needle aspirations were performed with a cytotechnologist or
cytopathologist present to prepare and review the retrieved sample to ensure
the adequacy of its quality. Therefore, the number of passes varied (range,
two to nine passes) as required for diagnosis. All thirty-five fine-needle
aspirations involving bone, soft tissues, or articular sites were done with a
22-gauge magnetic resonance imaging-compatible Lufkin aspiration cytology
biopsy needle (E-Z-EM) that was 5, 10, 15, or 20 cm long.
Pathological Analysis
Biopsy specimens were classified as diagnostic or
nondiagnostic13.
Diagnostic indicated that sufficient material had been obtained for a
histopathological or cytological analysis to yield a diagnosis of a malignant
or benign lesion. Nondiagnostic referred to cases with insufficient
material for pathological or cytological analysis. All nondiagnostic cases
underwent another diagnostic procedure. For each lesion, a surgical
pathologist with experience diagnosing musculoskeletal lesions evaluated the
histological features of the core-needle-biopsy samples and a cytopathologist
with experience diagnosing musculoskeletal lesions evaluated the cytological
features of the fine-needle-aspiration samples. The results of both the
core-needle biopsies and the fine-needle aspirations were integrated into a
summary pathological diagnosis.
Reference Standard
An independent reference standard was used for all cases except for twelve
in which the magnetic resonance imaging-guided biopsy led to a definitive
diagnosis of metastatic neoplasm or high-grade malignant tumor and treatment
was instituted on the basis of that biopsy result. In the remaining cases, the
reference standard consisted of pathological examination of specimens obtained
at a subsequent surgical procedure (a biopsy or resection; eighteen cases) or
with a subsequent repeat imaging-guided biopsy (one), or it consisted of
follow-up imaging performed for at least six months (average ten months;
range, six to twenty-four months), which showed no progression (fourteen
cases). This information was integrated into the final diagnosis. The final
diagnoses for the twenty bone lesions were metastasis (nine), normal marrow
(three), fibrosis (three), lipoma (one), Paget disease (one), sarcoidosis
(one), hemangioendothelioma (one), and infection (one). The final diagnoses
for the extra-articular soft-tissue lesions were fibrosis (four, with no
recurrent neoplasm), sarcoma (four, including two pleomorphic liposarcomas,
one epithelioid sarcoma, and one myxosarcoma), a vascular lesion (three,
including one vascular malformation, one intramuscular angioma, and one
hemangioma), peripheral nerve sheath tumor (two), amyloid deposit (one),
metastasis (one), myxoma (one), and infection (one). The final diagnoses for
the seven intra-articular soft-tissue lesions were pigmented villonodular
synovitis (one), synovial chondromatosis (one), normal (two, with no
recurrence of pigmented villonodular synovitis), ganglion (one), nonspecific
synovitis (one), and a malignant tumor (one undifferentiated round and
spindle-cell neoplasm).
Complications
Complications were determined by reviewing the radiology and hospital
information systems and clinic notes. Major complications were defined,
according to the American College of Radiology guidelines for percutaneous
biopsy14, as
complications that result in admission to the hospital for therapy (for
outpatient procedures), an unplanned increase in the level of care, prolonged
hospitalization, permanent adverse sequelae, or death.
Statistical Analysis
The results were analyzed for the entire group overall and separately for
each site subgroup (bone, extra-articular soft tissue, and intra-articular
soft tissue). Diagnostic performance was assessed by determining diagnostic
yield and diagnostic accuracy. Diagnostic yield was calculated by the formula:
[number of diagnostic cases/total number of cases] × 100%, with the
numerator equaling the number of interpretable samples and the denominator
equaling the number of samples submitted for interpretation. (For this study,
one biopsy procedure equals one sample obtained with a core-needle biopsy and
one obtained with a fine-needle aspiration, when both procedures were done for
a single lesion). Diagnostic accuracy was determined on the basis of the
diagnostic cases, with the nondiagnostic cases excluded. Each diagnostic case
was classified as either true-positive, true-negative, false-positive, or
false-negative, and the sensitivity, specificity, positive predictive value,
and negative predictive value were calculated.
Diagnostic Performance
Asummary of the diagnostic performance is presented in
Table I.
Diagnostic Yield
The diagnostic yield was 91% (forty-one of the forty-five biopsies yielded
sufficient material for a diagnosis) overall, 95% (nineteen of twenty) for the
bone lesions, 94% (seventeen of eighteen) for the extra-articular soft-tissue
lesions, and 71% (five of seven) for the intra-articular soft-tissue lesions.
In each nondiagnostic case, a subsequent procedure was performed to ascertain
the diagnosis. In the nondiagnostic case at the bone site, analysis of
specimens obtained with a subsequent surgical excision showed acute-on-chronic
osteomyelitis. In the nondiagnostic case at the extra-articular soft-tissue
site, analysis of specimens obtained with a subsequent surgical excision
showed a hematoma. One intra-articular soft-tissue lesion (in the knee) for
which the original biopsy was nondiagnostic was found to be villonodular
synovitis when a subsequent biopsy was done during arthroscopy. The other
nondiagnostic case at an intra-articular soft-tissue site was an incidental
lesion in a hip joint that demonstrated imaging characteristics favoring a
diagnosis of synovial chondromatosis. The patient declined to have surgery and
a repeat biopsy but underwent surveillance imaging and clinical follow-up,
which revealed no aggressive features of the lesion.
Diagnostic Accuracy
Calculation of the diagnostic accuracy for all forty-one lesions from which
sufficient specimens had been obtained revealed a sensitivity of 0.86, a
specificity of 1.00, a positive predictive value of 1.00, and a negative
predictive value of 0.76. The respective values for the nineteen bone lesions
from which sufficient specimens had been obtained were 0.92, 1.00, 1.00, and
0.86. There were twelve true-positive results (nine metastases, one
hemangioendothelioma, one ossifying lipoma, and one case of Paget disease) and
six true-negative results (three cases of fibrosis and three cases of normal
bone). There were no false-positive results. There was one false-negative
result; this was an iliac lesion in a patient with sarcoidosis from which the
biopsy obtained only normal bone and bone marrow. The lesion subsequently
increased in size from 2 to 3.5 cm and became visible on computed tomography
imaging. A computed tomography-guided biopsy done eighteen months after the
magnetic resonance imaging-guided biopsy showed noncaseating granulomas,
confirming the diagnosis of sarcoidosis.
Calculation of the diagnostic accuracy for the seventeen extra-articular
soft-tissue lesions from which sufficient specimens had been obtained showed a
sensitivity of 0.77, a specificity of 1.00, a positive predictive value of
1.00, and a negative predictive value of 0.57. There were ten true-positive
results (two sarcomas, two recurrent sarcomas [Figs.
1-A,
1-B, and
1-C], one peripheral nerve
sheath tumor, one myxoma, one angioma, one metastasis, one amyloid deposit,
and one infection). In two extra-articular soft-tissue lesions for which a
prior surgical biopsy had been considered either indeterminate (one case) or
to show only a low-intermediate-grade sarcoma (the other case), magnetic
resonance imaging-guided biopsy showed high-grade material and allowed the
institution of appropriate therapy. There were four true-negative results (two
cases of fibrosis at the postoperative site of a previous resection of a
sarcoma, one case of cartilage metaplasia and fibrous tissue, and one case of
chronic inflammation related to a reactive lymph node). There were no
false-positive results. There were three false-negative results. In these
cases, the biopsy specimens showed some normal tissue, fibrotic reaction, and
inflammation but the final diagnoses established with a surgical excision or
biopsy were a peripheral nerve sheath tumor, a soft-tissue hemangioma, and
intramuscular vascular malformation.
With regard to the diagnostic accuracy for the five intraarticular
soft-tissue lesions from which sufficient specimens had been obtained, the
sensitivity was 1.00, the specificity was 1.00, the positive predictive value
was 1.00, and the negative predictive value was 1.00. There were two
true-positive results (one undifferentiated sarcoma
[Figs. 2-A, 2-B,
2-C, 2-D] and one ganglion) and
three true-negative results (two cases of normal tissue [no evidence of
pigmented villonodular synovitis] and one case of nonspecific synovitis).
There were no false-positive or false-negative results.
Complications
All lesions referred for biopsy were visible on the images obtained with
the 0.5-T open-configuration interventional magnetic resonance imaging system.
In all cases, a safe approach was possible with use of the magnetic resonance
imaging guidance and the needle could be visualized on the images. There was
one major complication: a patient experienced an exacerbation of
neuropathic-type pain, with a new lancinating quality, during a soft-tissue
biopsy of a peripheral nerve sheath tumor. This was managed conservatively
with pain medication and amitriptyline hydrochloride (Elavil). The pain
decreased substantially after forty-eight hours but did not completely resolve
until the time of excision about three weeks later. There were no
procedure-related major complications such as hemorrhage or vascular injuries.
There was no documented tumor recurrence along any biopsy tract during the
follow-up period. No infections resulted from the needle biopsies, and there
was no complication related to the use of the magnetic resonance imaging
system or to the magnetic environment.
This study showed that magnetic resonance imaging-guided percutaneous
biopsy of selected musculoskeletal lesions is safe and has favorable
diagnostic performance characteristics. The overall accuracy of non-magnetic
resonance imaging-guided musculoskeletal biopsies in reported case series has
ranged from 50% to
96%15-25.
The variability of these results may be due to variations in sample size (the
number of lesions biopsied), the spectrum of lesions (the study population),
specimen types, and reference standard definitions. The results in our series
were similar or superior to those in the above investigations. In particular,
they were similar to those of Carrasco et
al.20, who reported
that the diagnostic accuracy was generally higher for malignant tumors than
for benign lesions. Among the bone lesions in our study, one case of
sarcoidosis was missed. Similarly, the biopsies were false-negative for three
extra-articular soft-tissue lesions, which were ultimately shown to be benign
tumors (peripheral nerve sheath tumor, hemangioma, and intramuscular vascular
malformation). The diagnostic performance of the biopsies of the bone and
extra-articular soft-tissue lesions in our series was also similar or superior
to that in several reports on diagnostic magnetic resonance imaging-guided
musculoskeletal
biopsies2-9,
in which the number of biopsies ranged from five to thirty-six.
As a guidance modality, magnetic resonance imaging has several favorable
characteristics, including superb image contrast between tissues, a
cross-sectional technique with an easily adjustable imaging plane, and no
ionizing radiation. As a result of superior contrast between soft tissue and
bone marrow, magnetic resonance imaging can identify cystic and necrotic areas
more readily than unenhanced computed tomography can. Careful assessment of
the internal composition of the tumors was important for targeting the needle
toward solid components in our study. We also used contrast medium in selected
circumstances to optimize diagnostic yield and accuracy by targeting the most
aggressive components of a lesion. Furthermore, there are certain lesions,
particularly marrow abnormalities, that may be visualized only by magnetic
resonance imaging. The multiplanar capabilities and virtually unlimited
section orientation of magnetic resonance imaging guidance are particularly
helpful for targeting masses that are not safely accessible in the direct
axial plane. Magnetic resonance imaging allows easy localization of
neurovascular structures and the ability to use flow-sensitive pulse sequences
that depict vascular anatomy in order to avoid complications. Lewin et al.
reported their experience with an interactive magnetic resonance
imaging-guided biopsy system for a variety of lesions throughout the body,
including twenty-three musculoskeletal
lesions3, and Ojala
et al. evaluated the feasibility of the use of a magnetic resonance
imaging-compatible optical tracking-guided bone-biopsy system (similar to
ours) in five different anatomic
areas4. These
reports emphasized that access to sites throughout the body was achieved with
successful needle placement in all cases. Likewise, we were able to safely
access all of the lesion sites in our series. A lack of ionizing radiation is
an advantage of using ultrasound and magnetic resonance imaging instead of
fluoroscopy, computed tomography, and computed tomography fluoroscopy.
Computed tomography imaging is extremely useful and the predominant modality
for targeting bone lesions. It is not likely to be replaced by magnetic
resonance imaging guidance in the near future. However, the use of realtime
computed tomography fluoroscopy increases the radiation dose to the operator
and the patient. The avoidance of exposure to ionizing radiation was relevant
for a pregnant patient in our series.
Although there are some inherent advantages of using magnetic resonance
imaging as a guidance modality, there are also several disadvantages. These
include the cost of deploying and maintaining a specialized magnet or
modifying an existing magnet and suite for interventional use and the
currently higher cost of magnetic resonance imaging-compatible biopsy
equipment. There are fewer choices for needles when they must be compatible
with magnetic resonance imaging. There are also specific contraindications to
the use of magnetic resonance imaging, including the presence of pacemakers,
certain cerebral aneurysm clips, cochlear implants, or other strongly
ferromagnetic material near critical locations. In addition, the performance
of procedures in a magnetic resonance imaging interventional suite requires
specially designed and tested equipment for patient monitoring, but this need
is similar to that for a diagnostic magnetic resonance imaging suite.
A unique aspect of our series is the inclusion of intraarticular
soft-tissue lesions. There has been little work involving image-guided
synovial biopsies. In our study, the diagnostic yield in this subgroup (71%;
five of seven) was inferior to that in the other lesion subgroups. The
intra-articular soft-tissue biopsies that yielded sufficient material were
highly accurate, but this finding must be viewed in the context of the
restricted diagnostic possibilities (the purpose of most of these biopsies was
to confirm or exclude a diagnosis of pigmented villonodular synovitis) and the
small number of procedures. With respect to obtaining a large specimen, the
configuration of some joints and the access route that is achievable are not
favorable for using a side-cutting biopsy needle and thus a front-cutting
vacuum-assisted needle was found to be better. A method for performing
synovial biopsy under ultrasound guidance with use of a portal and forceps was
described to have a diagnostic yield of 89% (thirty-three of
thirty-seven)26.
Development of a similar magnetic resonance imaging-compatible device may
increase the diagnostic yield of biopsies of intra-articular soft-tissue
lesions.
Our study had some limitations. There was no direct comparison of magnetic
resonance imaging with computed tomography, fluoroscopy, or ultrasound as the
guiding modality. In our series, magnetic resonance imaging guidance was
predominantly used for a specific reason, which introduced a selection bias.
However, the lesions were often chosen because they would have been difficult
to biopsy with use of other imaging modalities for guidance. We also did not
compare the usefulness of different needles. We employed a variety of needles
during our study, and in some cases more than one needle was used. We did not
focus on cost analysis or procedure time, which may be important
characteristics to compare with other modalities and between guidance
methods.
In summary, magnetic resonance imaging-guided percutaneous musculoskeletal
biopsies of bone and extra-articular soft-tissue lesions can be performed
safely and accurately. This technique may be considered supplementary to other
imaging modalities for biopsy guidance and can serve a problem-solving role as
a tool for lesions that would be difficult to visualize, access, or monitor
with the other modalities. ?